New Preclinical Testing Tools Help Researchers Tailor Treatment but Can They Fully Replace Mice?
In Precision Medicine Online, industry experts weigh in on the FDA’s decision to ease requirements for animal testing in preclinical research. Mary Duseau, President of Molecular Devices, calls the FDA’s shift away from mandatory animal testing “a game changer” for drug development. She highlights how human-derived 3D models like organoids can reduce time, cost, and waste in the drug pipeline—especially for precision medicines.